[{"address1": "3805 Old Easton Road", "city": "Doylestown", "state": "PA", "zip": "18902", "country": "United States", "phone": "215 948 4119", "website": "https://aprea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers; and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Oren  Gilad Ph.D.", "age": 57, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 575490, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John P. Hamill CPA", "age": 61, "title": "Senior VP, CFO, Principal Accounting Officer & Secretary", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 444280, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lars B. Abrahmsen Ph.D.", "age": 68, "title": "Senior VP & Chief Scientific Officer", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Wiley", "age": 57, "title": "Senior Vice President of Corporate Development & Strategy", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michel  Afargan Ph.D.", "title": "Head of Pharmacology Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ze'ev  Weiss B.Sc., C.P.A.", "age": 63, "title": "Chief Business Advisor", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Andrea  Epstein", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1767225600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.9401, "open": 0.98, "dayLow": 0.94, "dayHigh": 0.98, "regularMarketPreviousClose": 0.9401, "regularMarketOpen": 0.98, "regularMarketDayLow": 0.94, "regularMarketDayHigh": 0.98, "payoutRatio": 0.0, "beta": 1.609, "forwardPE": -1.0990698, "volume": 87417, "regularMarketVolume": 87417, "averageVolume": 99031, "averageVolume10days": 89860, "averageDailyVolume10Day": 89860, "bid": 0.9143, "ask": 0.9515, "bidSize": 1, "askSize": 1, "marketCap": 6610576, "fiftyTwoWeekLow": 0.84, "fiftyTwoWeekHigh": 4.65, "allTimeHigh": 1062.2, "allTimeLow": 0.474, "priceToSalesTrailing12Months": 13.539631, "fiftyDayAverage": 1.09636, "twoHundredDayAverage": 1.5237, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -7025843, "profitMargins": 0.0, "floatShares": 4595874, "sharesOutstanding": 6993838, "sharesShort": 34578, "sharesShortPriorMonth": 63277, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0049, "heldPercentInsiders": 0.19543, "heldPercentInstitutions": 0.23171, "shortRatio": 0.48, "shortPercentOfFloat": 0.0055, "impliedSharesOutstanding": 6993838, "bookValue": 1.825, "priceToBook": 0.5179178, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -13038738, "trailingEps": -2.12, "forwardEps": -0.86, "lastSplitFactor": "1:20", "lastSplitDate": 1676246400, "enterpriseToRevenue": -14.39, "enterpriseToEbitda": 0.509, "52WeekChange": -0.7251462, "SandP52WeekChange": 0.18594909, "quoteType": "EQUITY", "currentPrice": 0.9452, "targetHighPrice": 11.0, "targetLowPrice": 5.0, "targetMeanPrice": 7.0, "targetMedianPrice": 5.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 13718052, "totalCashPerShare": 2.174, "ebitda": -13795074, "totalDebt": 0, "quickRatio": 5.117, "currentRatio": 5.201, "totalRevenue": 488239, "revenuePerShare": 0.08, "returnOnAssets": -0.41904, "returnOnEquity": -0.74724, "grossProfits": -7905043, "freeCashflow": -9065156, "operatingCashflow": -13444051, "revenueGrowth": -0.995, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -1686.8983, "financialCurrency": "USD", "symbol": "APRE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 0.542497, "regularMarketPrice": 0.9452, "exchange": "NCM", "messageBoardId": "finmb_329831339", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Aprea Therapeutics, Inc.", "longName": "Aprea Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1768001821, "regularMarketTime": 1767992400, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1570109400000, "postMarketChangePercent": 1.5658011, "postMarketPrice": 0.96, "postMarketChange": 0.0147999525, "regularMarketChange": 0.00510001, "regularMarketDayRange": "0.94 - 0.98", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 99031, "fiftyTwoWeekLowChange": 0.10520005, "fiftyTwoWeekLowChangePercent": 0.12523817, "fiftyTwoWeekRange": "0.84 - 4.65", "fiftyTwoWeekHighChange": -3.7048001, "fiftyTwoWeekHighChangePercent": -0.7967312, "fiftyTwoWeekChangePercent": -72.51462, "earningsTimestampStart": 1754915400, "earningsTimestampEnd": 1755261000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.12, "epsForward": -0.86, "epsCurrentYear": -1.96, "priceEpsCurrentYear": -0.4822449, "fiftyDayAverageChange": -0.15115994, "fiftyDayAverageChangePercent": -0.13787436, "twoHundredDayAverageChange": -0.5785, "twoHundredDayAverageChangePercent": -0.3796679, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Aprea Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]